Tri Locum Partners LP Portfolio Holdings

Tri Locum Partners LP

  • $364 Million
  • Q3 2025

Tri Locum Partners LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $364 Million distributed in 18 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Johnson & Johnson with a value of $56.2M, United Therapeutics Corp with a value of $51.2M, Merck & Co., Inc. with a value of $37.5M, Axsome Therapeutics, Inc. with a value of $35.5M, and Ascendis Pharma A/S with a value of $34.8M.

Examining the 13F form we can see an increase of $86M in the current position value, from $278M to 364M.

Tri Locum Partners LP is based out at New York, NY

Below you can find more details about Tri Locum Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $364 Million
Healthcare: $364 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$522B
$56.2 Million 15.44% of portfolio
302,831
Q3 2025 New
$235B
$37.5 Million 10.31% of portfolio
446,874
Q3 2025 New
$414B
$20.8 Million 5.7% of portfolio
89,621
Q3 2025 Added 61.01%

Summary

  • Portfolio
  • No. of Stocks 18
  • Current Value $364 Million
  • Prior Value $278 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 6 stocks
  • Additional Purchases 6 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Tri Locum Partners LP Portfolio

Follow Tri Locum Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email